Newer glucose-lowering drugs and risk of dementia: A systematic review and meta-analysis of observational studies.

Newer GLDs were associated with a decreased risk of all-cause dementia in people with T2D. Because of the observational nature and significant heterogeneity between studies, the results should be interpreted with caution. Further research is warranted to confirm our findings.